Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

MDGLMDGL

Showing 7 of 15 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in Madrigal Pharmaceuticals, Inc.

Yes. Janus Henderson Group holds 2,018,647 shares of MDGL, worth $1.1B, as of its Q1 2026 13F filing. It increased the position by 433,804 shares (+27.4%) from Q4 2025. Janus Henderson Group has held MDGL since Q3 2022, across 15 quarterly 13F filings. MDGL is 0.5% of Janus Henderson Group's reported 13F portfolio.

Current Value

$1.1B

Current Shares

2M

Total Value Change

+$525.8M

Total Shares Change

-459,513

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2M
+27.4%
$1.1B0.5%$523.47
56
2025-Q4
Decreased
1.6M
-14.0%
$918.2M0.4%$582.34
0
2025-Q3
Decreased
1.8M
-15.9%
$845.3M0.4%$458.66
0
2025-Q2
Decreased
2.2M
-0.6%
$663.3M0.3%$302.64
0
2025-Q1
Decreased
2.2M
-0.1%
$723.1M0.4%$331.23
0
2024-Q4
Decreased
2.2M
-10.9%
$681.4M0.3%$308.57
0
2024-Q3
Decreased
2.5M
-0.3%
$525.9M0.3%$212.22
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used